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1033-115 Impact of Diabetes Mellitus on Abnormal Heart Rate 
Recovery After Exercise
Andrea De Lorenzo, Adriana J. Soares, Ronaldo L. Lima, Estacio de Sa University, Rio 
de Janeiro, Brazil, Federal University of Rio de Janeiro, Brazil
Background: Abnormal heart rate recovery (HRR) after exercise has been the subject of
extensive investigations due to its association with increased mortality. Its pathophysiol-
ogy has been linked to autonomic imbalance but is still a matter of debate. This study
aimed to determine the relationship between diabetes mellitus, a condition with a known
high prevalence of autonomic neuropathy, and abnormal HRR after exercise. Methods:
2,189 consecutive patients (59% males, age 56.7 ± 10.5 years) who underwent exercise/
rest Tc-99m sestamibi myocardial perfusion single-photon emission computed tomogra-
phy (SPECT) were studied. Patients taking beta-blockers or calcium-channel antagonists
were excluded. A symptom-limited exercise treadmill test (ETT) was performed accord-
ing to a Bruce protocol. Myocardial perfusion SPECT was semiquantitatively analyzed
using a 17-segment left ventricular model and a 5-point scale (graded from 0-normal
tracer activity, to 4-absence of detectable tracer activity). Summed stress and rest scores
(SSS, SRS) were obtained by adding segmental scores from stress and rest images,
respectively; the summed difference score (SDS) was calculated as the difference
between SSS and SRS. A multivariate analysis was used to determine the independent
predictors of abnormal HRR among clinical, ETT and SPECT variables. Results: 253
patients (11.6%) were diabetics. Abnormal HRR at 1 minute after exercise was more
prevalent among diabetics than nondiabetics (17.4% vs 12.4%; p<0.05). On multivariate
analysis, however, after adjustment for other variables, diabetes was not an independent
predictor of abnormal HRR. For the overall population, as well as for the subgroup of dia-
betic patients, the significant predictors of abnormal HRR were age (p<0.0001), resting
heart rate (p<0.0001), inability to reach 85% of maximal predicted heart rate (p<0.005),
exercise duration (p<0.0001), and the SRS (p=0.01). Conclusion: The mechanisms
underlying abnormal HRR may be unrelated to diabetic autonomic neuropathy. Abnormal
HRR is significantly related to perfusion defect extent and severity at rest and may most
likely be a consequence of previous myocardial damage.
1033-116 Optimizing Exercise Protocols for Heart Failure Trials
Rochelle L. Goldsmith, Joshua W. Trufant, Gillian M. Mueller, M. Allison Arwady, Daniel 
Burkhoff, Columbia University, New York, NY
Background: Peak oxygen consumption (PVO2) is often the primary endpoint in heart
failure (CHF) trials. Ramped treadmill protocols 8-12 min in duration yield cleaner PVO2
data and a more accurate estimate of exercise capacity. We sought to provide a frame-
work for developing ramped protocols consistent with these guidelines that target CHF
populations of various severities.
Methods: We conducted a retrospective study of 465 consecutive exercise tests of CHF
pts with PVO2 <20.0 ml/kg/min. All tests were done on the Modified Naughton treadmill
protocol (MNTP), the standard protocol for testing CHF pts. We excluded all sub-maximal
tests (RER <1.09) and stratified severity of CHF by defining ranges of PVO2. To quantify
peak workload, we converted the speed and grade reached by each pt to METs using the
American College of Sports Medicine algorithm (e.g., 2.0 mph, 7.0% grade=6.4 METs
during min 10 and 11 of the MNTP).
Results: The table indicates the mean peak workload achieved by pts in each PVO2
range.
The MNTP tests performed by pts with PVO2 _12 ml/kg/min or >16ml/kg/min were too
short or too long, respectively, to fall in the range 5.4-6.4 METs demanded at min 8-12 of
the MNTP.
Conclusion: Given the peak workload guidelines above, new ramped protocols can be
tailored to a trial’s target CHF functional class. For example, a ramped protocol that
increases 1 mph and 1% grade each min would reach a workload range of 3.9-5.8 METs
in min 8-12, which would be appropriate for patients with moderate to severe CHF.
1033-117 Ventilatory Response to Early Phase of Exercise: An 
Useful Index for Comprehensive Clinical Assessment of 
Patients With Heart Failure and Novel Predictor of 
Prognosis
Tomasz Witkowski, Ewa Jankowska, Robert Zymlinski, Agnieszka Kus-Klinowska, 
Waldemar Banasiak, Piotr Ponikowski, Military Hospital, Wroclaw, Poland
Background. Assessment of ventilatory response to exercise has been applied for the
clinical evaluation and risk stratification in pts with chronic heart failure (CHF). In most
studies ventilatory data were derived from the whole maximal cardiopulmonary exercise
testing (CPX). Whether, ventilatory response to early phase of exercise carries compara-
ble clinical and prognostic information remains unknown.
Methods. We investigated 202 consecutive CHF pts (175 men,age:59±11 yrs, NYHA
class I/II/III/IV:16/101/66/19; LVEF: 32±8%) who underwent CPX. Ventilatory response to
exercise, expressed as VE-VCO2 slope was calculated 1)throughout the whole CPX (VE-
VCO2 100%) and 2)throughout early phase of exercise - i.e. during the first 180 seconds
(VE-VCO2 180s).
Results. CHF pts demonstrated decreased peak oxygen consumption (peakVO2,
mean:15.2 ml/kg/min) and elevated values of VE-VCO2 100% and VE-VCO2 180s
(mean:35.8 and 34.4, respectively, all p<0.0001 vs reference values in our laboratory).
Ventilatory response to early and whole exercise were strongly interrelated (r2=0.63,
p<0.0001). Augmented VE-VCO2 180s identified pts with more advanced disease by the
relations with peakVO2: r=-0.38 (p<0.0001), quality of life assessed using Minnesota
questionnaire score: r=0.26 (p<0.05), NYHA class: r=0.23, p=0.001. VE-VCO2 180s did
not correlate with age, LVEF, CHF aetiology. VE-VCO2 180s had good reproducibility
with variability coefficient=8.5% (2 CPX within 2-7 days, in 14 patients). During the follow-
up (mean: 669±396 days) 40 (20%) patients died. Elevated VE-VCO2 180s (>
mean+2SD of age-matched controls, ie VE-VCO2 180s >32.5) was related to impaired
survival in univariate analysis (hazard ratio 2.8, 95%CI: 1.5-5.5, p=0.002). Multivariate
analysis identified only VE-VCO2 180s (p<0.05), but not NYHA class (p=0.1) and
peakVO2 (p=0.2) as conveying significant independent prognostic information.
Conclusions. In pts with CHF an excessive ventilation to early phase of exercise carries
an important clinical and prognostic information. Our findings extend the application of
the ventilatory assessment for prognostic stratification to CHF pts who are not able to
perform maximal CPX.
1033-118 Noninvasive Assessment of Coronary Artery Flow and 
Reserve in Top Athletes: Relationship With Oxygen 
Uptake
Fausto Rigo, Carlo Zanella, Valeria Cutaia, Ugo Coli, Claudio Rigo, Antonio Raviele, 
Mestre-Venice, Italy
Background: Coronary flow reserve (CFR) can be measured by transthoracic echocar-
diography (TTE) during vasodilator stress on mid-distal left anterior descending (LAD).
The Athletes (A) have higher aerobic performances (VO2max) in comparison with seden-
tary subjects. The aim of our study was to verify the relationship between CFR and
VO2max in A.
Methods: Starting from January 2002, 36 consecutive elite soccer A (36 males;
age=29±8 years) were evaluated by stress echocardiography. TTE (S8 probe, second
harmonic 7 MHz, HP 5500, Agilent technology). Mid-distal LAD coronary artery was
imaged from a modified apical two-chamber view. Wherever color-coded blood flow from
the baseline could not be obtained, contrast enhancement with Levovist (Schering AG,
300 mg/ml/min) was used. Peak diastolic coronary flow velocity of each coronary artery
was recorded by pulsed Doppler under the guidance of Color Doppler flow mapping. CFR
was calculated as the ratio of dipyridamole /rest peak diastolic flow velocity (0,84 mg over
6 m').
Results: Interpretable rest-peak signals were obtained in all 36 A for LAD (100%). The
CFR mean value on LAD was 4,5±5 (range:2,8-5,9); the mean value of VO2max was
40±6 ml/Kg/min(range:36-45 ml/Kg/min). CFR and VO2max were significantly correlated
(r=0.73; p<0.0001).
Conclusion: With latest generation, high frequency, second harmonic, contrast-
enhanced transthoracic echocardiography, imaging of LAD coronary artery flow and
assessment of flow reserve is highly feasible in A. This noninvasive parameter shows a
strict relationship with the aerobic performances in A, confirming that the VO2max repre-
sents a powerful metabolic trigger of CFR . Combined assessment of CFR and VO2max
allows a more complete functional evaluation of “ the athlete’s heart”.
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1049-103 B-Tpe Natriuretic Peptide Strongly Predicts Mortality in 
Intensive Care Unit Shock
Roderick H. Tung, Christine Garcia, Richard Pino, Alexander M. Morss, Kent 
Lewandrowski, Elizabeth Lewandrowski, B. Taylor Thompson, Michael A. Fifer, James L. 
Januzzi, Jr., Massachusetts General Hospital, Boston, MA
Background. B-type natriuretic peptide (BNP) levels predict mortality across a wide
range of cardiovascular syndromes. The prognostic utility of BNP in the intensive care
unit (ICU) setting has not been evaluated. Methods. 49 consecutive patients with shock
of various etiologies were enrolled. Analysis for BNP and calculation of APACHE II
scores were performed at the time of enrollment. Log-transformed BNP values were
divided into quartiles and correlated with in-hospital mortality. Logistic regression analy-
sis identified independent predictors of ICU death. Results. A wide range of BNP levels
was observed (<5 to >5000 pg/ml), with a mean BNP of 1133±1416 pg/ml. 18 patients
(37%) died during the course of the study. Mean (±SD) BNP levels were significantly
higher in patients dying than in survivors (1891±1853 vs 653±754 pg/ml, p=0.002).
Across log quartiles of BNP, there was significant correlation between logBNP levels and
mortality risk (Figure, p=0.006). Among the 13 patients in the highest log quartile (BNP
>1290 pg/ml) the risk of mortality was 62%. Notably, only one of these patients had car-
diogenic shock. Logistic regression analysis identified a logBNP level in the highest quar-
tile as a significant predictor of mortality (p=0.001). In contrast, the value of APACHE II
scores for predicting mortality was less evident.
Conclusion. Among ICU patients with shock of various etiologies, BNP levels powerfully
predicted mortality, and were superior to APACHE II scores for this purpose.
Peak VO2 (ml/kg/min) Peak Workload (METs)
<10.0 3.44 ± 1.28
10.0< VO2<12.0 4.24 ± 1.15
12.0< VO2<14.0 5.24 ± 1.19
14.0< VO2<16.0 5.92 ± 1.30
16.0< VO2<18.0 6.70 ± 1.25
18.0< VO2<20.0 7.26 ± 1.65
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1049-104 Correlation Between Brain Natriuretic Peptide and 
Cardiopulmonary Exercise Test Parameters in Patients 
With Chronic Heart Failure
Angela Beatrice Scardovi, Nadia Aspromonte, Claudio Coletta, Elena Cerquetani, Mauro 
Romano, Tiziana Di Giacomo, Manuela Greggi, Vincenzo Ceci, S. Spirito Hospital, 
Rome, Italy
We sought to evaluate if brain natriuretic peptide ( BNP) levels are associated with exer-
cise capacity determined by cardiopulmonary exercise test ( CPx ) in patients (pts) suffer-
ing from CHF. One-hundred sisty-five consecutive pts with CHF (age 70; beta blockers
53%; ischemic CHF: 52%; mean ejection fraction 41%; NYHA class I: 8%; II: 68 %; III:
24%) were considered. Mean BNP was 228 ± 277 pg/ml ( Biosite Diagnostic, Triage BNP
Test). CPx parameters were: VO2 peak (PVO2) (12,35+4,48 ml/Kg/min), anaerobic
threshold (AT) (9,43±2,80 ml/Kg/min), ventilation and carbon dioxide production ratio
(VE/VCO2) ( 38,02±8,27) , VE/VCO2 slope (33,82±7,78).
Results: A reverse statistically significant correlation between BNP level, PVO2 (r = -
0,297; p < 0,0001) and AT ( r = - 0,271; p<0,05) was respectively observed. A significant
correlation between BNP and abnormally high ventilatory response to exercise,
expressed as VE/VCO2 (r = 0,345; p<0,0001) and VE/VCO2 slope (r = 0,432; p<0,0001)
was observed. The ROC curves demonstrated BNP > 97 pg/ml to be the best cut-off for
determining PVO2 <14 ml/Kg/min, with overall accuracy of 71% (sensitivity: 65%; speci-
ficity: 65%), area under the curve (AUC): 0,69. Moreover, ROC demonstrated BNP > 138
pg/ml to be the best cut-off for determining PVO2 <10 ml/Kg/min, with overall accuracy
62% (sensitivity: 67%; specificity: 64%), AUC 0,72. BNP offers an alternative tool for dis-
tinguishing pts with moderate-to-severe reduction of exercise capacity.
1049-105 Increased Plasma Levels of Nt-ProANP and Nt-ProBrain 
Natriuretic Peptide as Markers of Cardiac Depression in 
Septic Patients
Ursula Hoffmann, Martina Brueckmann, Thomas Bertsch, Claudia Liebetrau, Martin 
Borggrefe, Guenter Huhle, Karl K. Haase, University Clinic Mannheim, Mannheim, 
Germany
Background: The family of natriuretic peptides comprises several structurally-related 22-
53-amino acid peptides, such as atrial natriuretic peptide (ANP) and brain natriuretic pep-
tide (BNP), which are vasoacitve peptides that have vasodilator and diuretic properties
and play an important role in cardiovascular homeostasis. The salutary cardiovascular
effects of natriuretic peptides suggest that ANP and BNP have a pathophysiological sig-
nificance in cardiac depression in septic patients. Aim of the present study was to deter-
mine plasma levels of the stable N-terminal prohormone forms of ANP (Nt-proANP) and
BNP (Nt-proBNP) in septic patients and healthy controls.
Patients and Methods: Nt-proANP and Nt-proBNP levels were measured in plasma
samples from 18 septic patients at day 1 of severe sepsis and 13 healthy controls by
ELISA- methods.
Results: The mean APACHE-Score of septic patients was 16.8 ± SD= 4.0 on day 1. Ten
of the 18 septic patients died (55% = non-survivors). Significantly higher concentrations
(p=0.006) of Nt-proANP were measured in non-survivors (MW=13415 fmol/l ± SEM =
3640) as compared to controls (MW=2274 fmol/ml ± SEM= 1043). There was also a sig-
nificantly difference between Nt-proANP levels in controls and survivors (p= 0.019).
There were no differences of Nt-proANP levels between survivors and non-survivors
(p=0.189). Levels of Nt-proBNP were also significantly higher in non-survivors
(MW=3439 fmol/l ± SEM=1246; p=0.010) and survivors (MW =1009 fmol/l ± SEM=
263;p=0.001) as compared to controls (MW = 200 fmol/l ± SEM=24). There was no sig-
nificant difference between concentrations of Nt-proBNP in the non-survivor and the sur-
vivor-group.
Conclusion: Nt-proANP and Nt-proBNP levels are elevated in the early course of septic
patients, possibly reflecting myocardial depression in severe sepsis.
1049-106 Endothelial Marker Big Endothelin-1 Is More 
Discriminant Than Brain Natriuretic Peptide to 
Categorize Patients With Congestive Heart Failure
Ronald Van Beneden, Michel P. Hermans, Sylvie A. Ahn, Jean-Marie Ketelslegers, 
Michel F. Rousseau, University of Louvain, Brussels, Belgium
Background: Brain Natriuretic Peptide (BNP) and Big Endothelin-1 (BigET-1) are
becoming central as diagnostic and prognostic neurohormonal markers to the manage-
ment of patients with congestive heart failure.
Methods: The Discriminant Ratio (DR) method (Levy JC et al. Am J Physiol 276: E365-
E375, 1999) was used to compare the respective performance of BNP and BigET-1 to
rank patients according to heart failure severity. The DR estimates the ability of a method
to discriminate subjects. It is obtained from the ratio of the underlying between-subject
standard deviation (SDu) to the within-subject SD (SDw). DRs were calculated from BNP
and BigET-1 duplicates, sampled on 2 consecutive days. Significance of differences in
DRs was p<0.05. Correlation coefficients between pairs of measurements were adjusted
in order to include an estimate of the underlying correlation, since standard coefficients,
due to the presence of within-subject variation, tend to underestimate the true correlation
between tests through attenuation. An unbiased estimation of the linear relationship
equation between methods was also derived.
Results: Plasma concentrations of BNP and BigET-1 were measured in duplicates in 31
heart failure patients (NYHA II–IV, mean EF 23%). Mean values of day 1 and day 2 (±SD)
were 75 (52) and 77 (52) pg/mL for BNP [normal values (range): 5.4 (2.5-12.8) pg/mL],
and 12.5 (7.4) and 12.0 (8.1) pg/mL for BigET-1 [normal values (range): 5.7 (4.0-7.6) pg/
mL], respectively. The difference between the DRs of BNP and BigET-1 (2.73 and 4.61
respectively) was statistically significant (p<0.05) in favor of a better discriminating ability
for BigET-1. Unadjusted Pearson coefficient between methods was 0.70, rising up to 0.83
following adjustment for attenuation. Slope and intercept of the unbiased estimation of
the linear relationship equation between measurements were 0.18 and -1.47 pg/mL,
respectively.
Conclusions: According to the DR method, BigET-1 appears able to better discriminate
a heart failure population than BNP. Although both markers are highly correlated in this
population, BigET-1 is the choice method to categorize patients with congestive heart fail-
ure.
1049-107 Natriuretic Peptides as Predictors of Clinical Course in 
Patients With End-Stage Heart Failure
Evgenij V. Potapov, Frank D. Wagner, Felix Hennig, Christian Müller, Rainer Michael, 
Hans B. Lehmkuhl, Roland Hetzer, Deutsches Herzzentrum Berlin, Berlin, Germany, 
Charité, Humboldt University, Germany
Background: The optimal timing for heart transplantation (HTx) or implantation of a ven-
tricular assist device (VAD) in patients with end-stage heart failure is a key issue.
Methods: In 86 patients with end stage heart failure requiring inotropic support and
scheduled for HTx or VAD implantation blood was sampled daily. Big endothelin-1 (big
ET-1) and natriuretic peptides (pro-ANP, ANP, NT-proBNP and BNP) were measured at
the end of the study. Clinical and hemodynamic parameters were also evaluated daily.
The patients were divided into groups with regard to the following endpoints: Group I –
immediate VAD placement due to profound cardiogenic shock on admission (n=10);
Group II – deterioration into cardiogenic shock after an initially stable clinical course
(n=26); Group III – stable clinical course allowed urgent HTx or VAD implantation (n=41);
Group IV – weaning from inotropic support (n=9). The data are presented as median val-
ues.
Results: On admission there were no differences in clinical parameters between the
